This inventor holds 8 USPTO granted patents and 17 published patent applications and 9 EPO patents. Top assignees: Gammadelta Therapeutics Ltd, King's College London, Cancer Research Technology Limited. Active years: 2023-2026.
Company Filing History:
5 out of 8 
5 out of 196 
2 out of 268 Years Active: 2023-2026
Title: Oliver Nussbaumer: Innovator in Cell Isolation and Expansion
Introduction
Oliver Nussbaumer is a prominent inventor based in London, GB. He has made significant contributions to the field of cell biology, particularly in the isolation and expansion of lymphocytes. With a total of 8 patents to his name, Nussbaumer's work has the potential to impact therapeutic approaches in immunology.
Latest Patents
One of his latest patents is titled "Novel Gene Armoring." This invention focuses on methods for isolating and expanding cells, specifically lymphocytes, from non-haematopoietic tissue samples. The method involves culturing a biopsy obtained from non-haematopoietic tissue in the presence of Interleukin-2 (IL-2) and Interleukin-15 (IL-15). The process culminates in the collection of a population of lymphocytes cultured from the tissue sample. Additionally, the patent outlines methods for subsequent expansion and the uses of the isolated cell populations.
Career Highlights
Throughout his career, Nussbaumer has worked with esteemed institutions such as King's College London and Gammadelta Therapeutics Ltd. His innovative approaches have garnered attention in the scientific community, contributing to advancements in cell therapy.
Collaborations
Nussbaumer has collaborated with notable figures in the field, including Adrian Hayday and Richard Woolf. These partnerships have further enriched his research and development efforts.
Conclusion
Oliver Nussbaumer stands out as a key innovator in the realm of cell isolation and expansion. His contributions through patents and collaborations continue to shape the future of immunological therapies.